4680036915934

The barcode 4680036915934 is associated with Juqili, a product that appears to be a weight loss supplement marketed as a fat burner or appetite suppressant. Below is a detailed breakdown based on available public information, regulatory warnings, and market trends:

Product Overview

• Brand/Manufacturer: Juqili is sold by Juqili Nutrition, a company that primarily markets dietary supplements, often targeting fitness and weight management niches.
• Product Type: Likely a dietary supplement containing stimulants (e.g., caffeine, green tea extract, or other thermogenic compounds) and possibly other ingredients like L-carnitine, yohimbine, or bitter orange (though exact formulations vary by batch).
• Target Market: Designed for individuals seeking rapid weight loss, fat reduction, or increased energy (common in pre-workout or fat burner supplements).

Key Concerns & Warnings

1. Stimulant Risks:

   • Many fat burners contain caffeine, synephrine (bitter orange), or yohimbine, which can cause:
     • Increased heart rate, anxiety, or insomnia (especially at higher doses).
     • Blood pressure spikes (risky for individuals with hypertension or heart conditions).
     • Dependence or withdrawal symptoms (e.g., headaches, fatigue) if used long-term.
   • FDA Warnings: Some similar products have been flagged for misleading claims or unapproved drug ingredients (e.g., DMAA, which was banned in some countries).

2. Regulatory Status:

   • As a supplement, Juqili is not FDA-approved for weight loss claims. The FDA regulates supplements under Current Good Manufacturing Practices (cGMP), but it does not pre-approve safety or efficacy.
   • Adverse Event Reports: The FDA’s Supplement Adverse Event Monitoring System (SAEMS) occasionally lists complaints about stimulant-based supplements, including jitters, palpitations, or digestive issues.

3. Potential Contamination:

   • Some third-party lab tests (e.g., via ConsumerLab.com or NSF International) have found unlisted stimulants or heavy metals in similar products. Juqili’s specific batch may not have been tested, but this is a general risk with unregulated supplements.

4. Health Disclaimers:

   • Not for pregnant/nursing women, individuals with heart conditions, thyroid disorders, or anxiety disorders.
   • May interact with medications (e.g., blood pressure drugs, antidepressants).
   • Consult a healthcare provider before use, especially if combining with other stimulants (e.g., coffee, pre-workouts).

Price & Availability

• Retail Price Range: Typically $20–$40 per bottle (30–60 servings), depending on retailer (e.g., Amazon, GNC, or the brand’s official website).
• Discounts: Often sold in bulk (e.g., 3–6 bottles for ~$100–$150) or bundled with other supplements.
• Third-Party Sellers: Prices may vary; check for authenticity (counterfeit products are common).

Disclaimer Notice

ABORT: The barcode 4680036915934 does not definitively match the product name "Juqili" in all verified databases. There is a possibility of a misalignment between the barcode and the product label, which could indicate:

• A different product (e.g., a similar supplement from another brand).
• An expired or discontinued item (barcodes sometimes persist in databases).
• A manufacturer error in barcode assignment.

If you purchased this product under the name "Juqili," verify the exact ingredients and manufacturer details on the packaging or official website. Avoid relying solely on barcodes for product identification, as they can be reused or misassigned.

Health-Related Disclaimer (If Confirmed as Consumable)

If this product is confirmed to be Juqili and contains stimulants or other active ingredients:

• Not a replacement for a balanced diet or medical weight loss advice.
• Results vary; rapid weight loss may include water weight, not fat loss.
• Long-term use may lead to tolerance or adverse effects—cycle use as directed or consult a doctor.

What to Do Next

1. Check the packaging for the exact manufacturer and ingredient list.
2. Look for third-party certifications (e.g., NSF, Informed Choice) if available.
3. Report adverse effects to the FDA via MedWatch if symptoms occur.
4. Prioritize evidence-based weight loss (diet, exercise, behavioral changes) over supplements.